Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno P Imbimbo

Showing results (1-10 of 142) with videos related to

Pageof 15
Sort By:
Journal of Alzheimer'S Disease : JAD|June 23, 2009
Why did tarenflurbil fail in Alzheimer's disease?Bruno P Imbimbo
Expert Opinion on Investigational Drugs|July 11, 2009
An update on the efficacy of non-steroidal anti-inflammatory drugs in Alzheimer's diseaseBruno P Imbimbo
Expert Opinion on Investigational Drugs|October 27, 2004
The potential role of non-steroidal anti-inflammatory drugs in treating Alzheimer's diseaseBruno P Imbimbo
Current Topics in Medicinal Chemistry|January 29, 2008
Therapeutic potential of gamma-secretase inhibitors and modulatorsBruno P Imbimbo
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 20, 2025
Rethinking biological biomarkers to track treatment efficacy in Alzheimer's disease: Focus on brain connectivityLorenzo Pini, Bruno P Imbimbo
Expert Opinion on Investigational Drugs|December 10, 2021
What have we learned from past failures of investigational drugs for Alzheimer's disease?Bruno P Imbimbo, Mark Watling
Journal of Alzheimer'S Disease : JAD|May 19, 2012
Metabolic-cognitive syndrome: metabolic approach for the management of Alzheimer's disease riskVincenza Frisardi, Bruno P Imbimbo
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 27, 2025
Targeting dementia prevention with semaglutide: The case for APOE4 homozygotesTimothy Daly, Bruno P Imbimbo
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 2, 2025
Enhancing uptake of antidiabetic drugs to reduce cardiometabolic risk and dementia burdenTimothy Daly, Bruno P Imbimbo
The New England Journal of Medicine|April 26, 2023
Lecanemab in Early Alzheimer's DiseaseNunzio Pomara, Bruno P Imbimbo
Pageof 15

Showing results (1-10 of 142) with videos related to

Sort By:
Pageof 15
Journal of Alzheimer'S Disease : JAD|June 23, 2009
Why did tarenflurbil fail in Alzheimer's disease?Bruno P Imbimbo
Expert Opinion on Investigational Drugs|July 11, 2009
An update on the efficacy of non-steroidal anti-inflammatory drugs in Alzheimer's diseaseBruno P Imbimbo
Expert Opinion on Investigational Drugs|October 27, 2004
The potential role of non-steroidal anti-inflammatory drugs in treating Alzheimer's diseaseBruno P Imbimbo
Current Topics in Medicinal Chemistry|January 29, 2008
Therapeutic potential of gamma-secretase inhibitors and modulatorsBruno P Imbimbo
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 20, 2025
Rethinking biological biomarkers to track treatment efficacy in Alzheimer's disease: Focus on brain connectivityLorenzo Pini, Bruno P Imbimbo
Expert Opinion on Investigational Drugs|December 10, 2021
What have we learned from past failures of investigational drugs for Alzheimer's disease?Bruno P Imbimbo, Mark Watling
Journal of Alzheimer'S Disease : JAD|May 19, 2012
Metabolic-cognitive syndrome: metabolic approach for the management of Alzheimer's disease riskVincenza Frisardi, Bruno P Imbimbo
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 27, 2025
Targeting dementia prevention with semaglutide: The case for APOE4 homozygotesTimothy Daly, Bruno P Imbimbo
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 2, 2025
Enhancing uptake of antidiabetic drugs to reduce cardiometabolic risk and dementia burdenTimothy Daly, Bruno P Imbimbo
The New England Journal of Medicine|April 26, 2023
Lecanemab in Early Alzheimer's DiseaseNunzio Pomara, Bruno P Imbimbo
Pageof 15